Progress in Survival Prognosis of Segmentectomy for 
Early-stage Non-small Cell Lung Cancer

Lung Cancer
22/09/2020

Zhongguo Fei Ai Za Zhi. 2020 Sep 20;23(9):830-836. doi: 10.3779/j.issn.1009-3419.2020.102.21.

ABSTRACT

Surgery is currently the most appropriate treatment for early-stage non-small cell lung cancer (NSCLC). Increasing unilateral or bilateral multiple primary lung cancer being found, segmentectomy has attracted wide attention for its unique advantages in the treatment for such tumors. Ground glass opacity dominant early-stage NSCLC is associated with a good prognosis and can be cured by segmentectomy, however, the treatment of solid-dominant NSCLC remains controversial owing to the invasive


nature. With the in-depth study on the lymph node metastasis pathway, radiological characteristics and molecular biology of NSCLC, a large part of solid nodules with certain characteristics can also be cured by segmentectomy. This paper reviews the research status and progress about the indication of segmentectomy. .